Uses of a glycoprotein VI (GPVI) inhibitor

Details for Australian Patent Application No. 2008319336 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Tandon, Narendra N.; Takizawa, Hisao; Liu, Yongge; Kambayashi, Junichi

Agent Davies Collison Cave

Pub. Number AU-A-2008319336

PCT Pub. Number WO2009/058326

Priority 60/984,334 31.10.07 US

Filing date 29 October 2008

Wipo publication date 7 May 2009

International Classifications

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/058326 Priority application(s): WO2009/058326

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008319348-System and method for electrically regenerating a particulate filter assembly of a generator set

2008319334-Solid catalyst system for biodiesel production